<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T21:29:51Z</responseDate>
  <request identifier="oai:figshare.com:article/34034746" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34034746</identifier>
        <datestamp>2026-09-30T17:27:32Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Summary of study characteristics, methods, and findings for included studies (n = 10).&lt;/p&gt;</dc:title>
          <dc:creator>Mahmood Ahmadi-hamedani (14233961)</dc:creator>
          <dc:creator>Kimia Satari (25145086)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>megakaryocyte cytology );</dc:subject>
          <dc:subject>marked methodological heterogeneity</dc:subject>
          <dc:subject>frequently necessitates sedation</dc:subject>
          <dc:subject>xlink "&gt; following</dc:subject>
          <dc:subject>xlink "&gt; aim</dc:subject>
          <dc:subject>standard data sheet</dc:subject>
          <dc:subject>related platelet production</dc:subject>
          <dc:subject>assessing megakaryocytic activity</dc:subject>
          <dc:subject>immature platelet fraction</dc:subject>
          <dc:subject>one study used</dc:subject>
          <dc:subject>35 records identified</dc:subject>
          <dc:subject>xlink "&gt; evidence</dc:subject>
          <dc:subject>full systematic review</dc:subject>
          <dc:subject>reticulated platelet parameters</dc:subject>
          <dc:subject>marrow reference standard</dc:subject>
          <dc:subject>classify primary studies</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>platelet status</dc:subject>
          <dc:subject>systematic review</dc:subject>
          <dc:subject>related immature</dc:subject>
          <dc:subject>reference criteria</dc:subject>
          <dc:subject>feline data</dc:subject>
          <dc:subject>reticulated platelets</dc:subject>
          <dc:subject>thrombopoietic activity</dc:subject>
          <dc:subject>marrow activity</dc:subject>
          <dc:subject>evidence generated</dc:subject>
          <dc:subject>evidence across</dc:subject>
          <dc:subject>scoping review</dc:subject>
          <dc:subject>small number</dc:subject>
          <dc:subject>scr guidelines</dc:subject>
          <dc:subject>scoping reviews</dc:subject>
          <dc:subject>remainder relied</dc:subject>
          <dc:subject>potential indicators</dc:subject>
          <dc:subject>marrow marker</dc:subject>
          <dc:subject>informative synthesis</dc:subject>
          <dc:subject>findings etc</dc:subject>
          <dc:subject>expensive procedure</dc:subject>
          <dc:subject>exhaustive search</dc:subject>
          <dc:subject>essentially limited</dc:subject>
          <dc:subject>ensure eligibility</dc:subject>
          <dc:subject>eligibility criteria</dc:subject>
          <dc:subject>currently feasible</dc:subject>
          <dc:subject>comprehensive assessment</dc:subject>
          <dc:subject>clinical information</dc:subject>
          <dc:subject>cab abstracts</dc:subject>
          <dc:description>&lt;p&gt;Summary of study characteristics, methods, and findings for included studies (n = 10).&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:27:24Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358333.t003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Summary_of_study_characteristics_methods_and_findings_for_included_studies_n_10_p_/34034746</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
